TickerGuard
Buy Day today: Neutral (47) Mixed market breadth · no major macro event
UTHR

United Therapeutics Corporation

Healthcare · Drug Manufacturers - Specialty & Generic

545.00$ +0.6% vs. previous close Closing price · As of: Oct 7, 2026

Statements

Balance Sheet

United Therapeutics Corporation (UTHR) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q2 26), "Total Assets" came in at 7,220 million USD. Tick rows to compare them in a chart.

Income Statement Balance Sheet Cash Flow Ratios
Annual Quarterly
Amounts Change % Common size %
Last 12 Full history
Download as CSV

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Balance Sheet UTHR
Line item Q3 16 Q4 16 Q1 17 Q2 17 Q3 17 Q4 17 Q1 18 Q2 18 Q3 18 Q4 18 Q1 19 Q2 19 Q3 19 Q4 19 Q1 20 Q2 20 Q3 20 Q4 20 Q1 21 Q2 21 Q3 21 Q4 21 Q1 22 Q2 22 Q3 22 Q4 22 Q1 23 Q2 23 Q3 23 Q4 23 Q1 24 Q2 24 Q3 24 Q4 24 Q1 25 Q2 25 Q3 25 Q4 25 Q1 26 Q2 26
2,269 2,326 2,561 2,692 2,936 2,879 3,020 3,245 3,412 3,401 3,727 3,899 4,000 3,913 4,026 4,219 4,411 4,615 4,641 4,845 5,049 5,169 5,360 5,543 5,782 6,045 6,346 6,681 7,024 7,167 6,495 6,723 7,123 7,364 7,744 7,908 7,351 7,880 6,714 7,220
1,386 1,425 1,504 1,564 1,639 1,448 1,634 1,624 1,609 1,768 1,943 2,140 1,933 1,865 1,846 1,894 1,868 2,167 2,014 2,318 2,386 2,324 2,587 2,684 3,056 3,380 3,193 3,213 3,459 3,551 3,249 3,620 4,000 3,874 3,940 3,827 3,494 3,703 2,872 3,484
953 1,023 1,123 1,006 1,068 705 933 746 656 669 791 881 720 738 875 685 670 739 832 942 909 895 813 795 967 961 1,164 1,067 1,108 1,208 1,252 1,356 1,554 1,697 1,900 1,593 1,137 1,557 1,074 1,803
1,033 1,051 1,156 1,115 1,211 1,430 1,257 1,213 1,238 1,416 1,605 1,786 1,570 1,486 1,545 1,561 1,581 1,835 1,731 1,968 2,000 1,931 2,268 2,255 2,616 2,839 2,863 2,679 2,876 2,994 2,708 2,972 3,327 3,267 3,321 3,049 2,768 1,557 2,154 2,662
225 215 188 274 252 297 211 251 215 176 160 181 184 151 150 172 152 157 141 173 213 199 171 173 232 220 135 273 259 279 307 291 342 279 322 379 298 350 312 310
92 100 107 114 114 108 102 103 101 101 96 97 94 93 92 90 88 87 92 90 97 94 88 90 91 102 103 103 104 112 120 137 147 158 165 169 177 183 178 194
488 489 494 502 522 546 578 626 665 700 701 716 678 739 739 744 736 732 714 716 727 781 784 791 841 862 897 939 – – – – – – – – – – – –
10 10 10 14 14 14 46 46 28 32 32 32 28 28 28 28 28 28 28 28 28 28 28 28 28 28 – – – 34 – – – 32 – – – 32 – –
24 24 23 32 32 32 46 46 139 139 139 130 130 130 130 130 130 130 17 17 17 17 17 17 17 17 45 45 44 81 115 115 112 80 112 112 117 117 116 114
420 463 485 896 847 778 632 660 700 612 1,389 1,332 1,284 1,133 1,077 1,126 1,128 1,220 1,196 1,205 1,219 1,210 1,184 1,225 1,219 1,248 1,223 1,270 1,312 1,182 1,157 1,026 1,022 920 937 734 761 784 813 820
315 333 428 839 789 445 318 350 372 277 270 464 470 463 207 255 259 323 302 311 320 305 293 332 316 343 325 370 744 804 861 832 873 738 722 527 546 561 599 608
– – – 250 250 250 250 250 – – 3.4 253 250 250 – – – – – – – – – – – – – – 300 400 400 400 400 300 200 – – 7.3 – –
119 8.1 106 127 143 8.4 203 216 205 23 139 164 161 9.9 130 153 177 4.1 165 190 211 3.8 166 197 220 4.1 240 292 333 5.6 305 325 364 6.0 367 432 468 7.1 498 498
0.0 0.0 0.0 0.0 0.0 250 250 250 250 250 1,050 800 750 600 800 800 800 800 800 800 800 800 800 800 800 800 800 800 500 300 200 100 – – – – – – – –
1,850 1,862 2,076 1,795 2,089 2,102 2,389 2,585 2,712 2,789 2,338 2,567 2,716 2,780 2,949 3,094 3,283 3,395 3,445 3,640 3,830 3,959 4,176 4,318 4,562 4,797 5,123 5,411 5,712 5,985 5,338 5,697 6,101 6,444 6,807 7,174 6,590 7,096 5,901 6,400
2,323 2,434 2,606 2,550 2,827 2,846 3,090 3,263 3,370 3,435 2,935 3,140 3,273 3,325 3,462 3,569 3,740 3,839 3,868 4,040 4,203 4,315 4,555 4,671 4,910 5,042 5,283 5,542 5,810 6,027 6,334 6,612 6,921 7,222 7,544 7,854 8,193 8,557 8,832 9,165
46 45 46 45 44 44 44 43 44 44 44 44 44 44 44 44 45 45 46 47 48 48 48 48 49 49 50 50 50 50 50 48 48 49 49 48 47 48 47 46

Showing the most recent 40 periods — older statements are on file for this stock.

Data as of: October 7, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?